Other
Dutasteride
5 Alpha-Reductase Inhibitor
Other names: Avodart
Taken for: Hair loss or an enlarged prostate (BPH)Taking it for something else? The entries here do not cover that use. The FAA may address it in the guidance for your condition. Ask your examiner.
Wait
48 hours
after the first dose
The FAA's MedGuide lists dutasteride (Avodart) as allowed, for alopecia (hair loss), benign prostatic hypertrophy (BPH) or polycystic ovarian disease (PCOS) [OL], with a wait of 48 hours after the first dose and none after later doses or after the final dose, used as prescribed; for PCOS, the entry under that use carries the FAA's PCOS worksheet as well.
Track your medicationsMore detail: dutasterideThe rest of Crosscheck's reading, in plain wordsOpen
The MedGuide defines allowed as acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present, and says wait times are not determined solely by the medication: an extended observation period may be required to verify clinical stability of the condition.
- 48 hours after the first dose: ground observation
Show the FAA's words: dutasterideThe official FAA wording: three passages, each with its document and dateOpen
Generic: dutasteride
Brand Name: Avodart
Drug Class: 5 Alpha-Reductase Inhibitor
Underlying Condition: Alopecia (Hair loss); Benign Prostatic Hypertrophy (BPH); Polycystic ovarian disease (PCOS) [OL]
Use: ALLOW
INITIAL Wait Time (after first dose): 48 hours
SUBSEQUENT Dose Wait Time (after each dose): None
DISCONTINUATION Wait Time (after final dose): None
Frequency Use Limit: As prescribed
ALLOWED: The medication is acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present.
Underlying Condition: Evaluating medication use requires considering the impact of safety of flight from both the medication and underlying condition. Wait times are not determined solely by the medication; an extended observation period may be required to verify clinical stability of the condition.